Clinical Trials Browser

Phase NA × pembrolizumab × Head & Neck × Clear all

NCT07343596 2026-04-22

Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery

Phase NA Recruiting

Mouth Neoplasms

NCT05047094 2026-04-06

Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

Phase NA Recruiting

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms

NCT05821751 2023-04-20

PRINCESS

Phase NA Unknown

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Neoplasm Metastasis

NCT04453046 2022-12-20

Hemopurifier Plus Pembrolizumab in Head and Neck Cancer

Phase NA Terminated

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms